Indication, For the treatment of clinical depression. Pharmacodynamics, Reboxetine is a selective noradrenaline reuptake inhibitor (NaRI), the first drug of new antidepressant class. Reboxetine is an a-ariloxybenzyl derivative …
Article by Reboxetine – Google Blog Search. Read entire story here.
News and insights about GAD, depression, phobias, OCD and panic attacks